Sort
326,823 grants matching “clinical trial”
Cellular and Molecular Studies of Bone Marrow Transplant
$2,394,938James L M Ferrara · Icahn School Of Medicine At Mount Sinai · P01 · FY2024 · CA
Dominantly Inherited Alzheimer Network Administrative Core
$2,394,859Randall J Bateman · Washington University · U19 · FY2020 · AG
Identifying small molecules with therapeutic effects in RELAFus -driven EPN, mand testing them in preclinical genetically engineered models of EPN
$2,394,581Kevan M. Shokat · Fred Hutchinson Cancer Research Center · U54 · FY2019 · CA
The effect of SPecialty cAre on Recovery from Cardiac arrest (the SPARC trial)
$2,394,542Jonathan Elmer · University Of Pittsburgh At Pittsburgh · R61 · FY2025 · HL
Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug Repurposing
$2,394,473Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · RF1 · FY2023 · AG
Lentiviral Gene Therapy for Sickle Cell Disease and Immunodeficiency Disorders
$2,394,432Brian P Sorrentino · St. Jude Children'S Research Hospital · P01 · FY2013 · HL
Tissue destruction and healing in Celiac Disease
$2,394,224Bana Jabri · University Of Chicago · RC2 · FY2025 · DK
Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts
$2,394,018Flavio Vincenti · University Of California, San Francisco · U01 · FY2015 · AI
Tissue destruction and healing in Celiac Disease
$2,394,001Bana Jabri · University Of Chicago · RC2 · FY2023 · DK
Clinical Coordinating Center Network of Excellence in Neuroscience Clinical Trial
$2,393,953Merit E Cudkowicz · Massachusetts General Hospital · U01 · FY2022 · NS
Case Clinical Trials Unit
$2,393,908Jeffrey M Jacobson · Case Western Reserve University · UM1 · FY2024 · AI
DF/HCC Prostate SPORE
$2,393,890Himisha Beltran · Dana-Farber Cancer Inst · P50 · FY2024 · CA
CENTER FOR HUMAN CELL THERAPY
$2,393,559Leslie Eric Silberstein · Immune Disease Institute, Inc. · U24 · FY2008 · HL
Vaccines for prescription opioid and heroin abuse
$2,393,499Paul Pentel · Hennepin Healthcare Research Institute · U01 · FY2017 · DA
PREVENTABLE Trial Implementation Phase
$2,393,279Karen P Alexander · Duke University · U19 · FY2024 · AG
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,393,230David S Guzick · University Of Rochester · UL1 · FY2006 · RR
NIH StrokeNet National Clinical Coordinating Center
$2,393,054Joseph Paul Broderick · University Of Cincinnati · U01 · FY2020 · NS
InHANCE: Imaging Innovation for Head And Neck Cancer Evaluation & Treatment Delivery
$2,392,505Kristy Brock · University Of Tx Md Anderson Can Ctr · P01 · FY2025 · CA
Augmenting AXL and MERTK function to restrain cognitive decline and improve health span in mouse models of Alzheimer's Disease
$2,392,160Carla Rothlin · Yale University · RF1 · FY2023 · AG
MATERNAL FETAL RESEARCH NETWORK: DATA COORDINATING CTR
$2,391,778George Washington University · U01 · FY2000 · HD
Individualizing Therapy for Kidney and Heart Transplant Recipients
$2,391,622Peter Scott Heeger · Icahn School Of Medicine At Mount Sinai · U01 · FY2010 · AI
GENE THERAPY FOR SICKLE CELL ANEMIA
$2,391,557Yeshiva University · P01 · FY2003 · HL
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM FOR AIDS
$2,391,459University Of North Carolina Chapel Hill · U01 · FY2001 · AI
NIH StrokeNet National Clinical Coordinating Center
$2,391,379Joseph Paul Broderick · University Of Cincinnati · U01 · FY2021 · NS
Calcium Signaling &Prefrontal Deficits in Schizophrenia
$2,391,375Yale University · P50 · FY2005 · MH